One of the largest gaps in Original Medicare is the one that gets the least attention until a serious illness arrives. Parts A and B carry no annual limit on what a beneficiary can be charged out of pocket, meaning the 20% coinsurance on doctor and outpatient care keeps running with no ceiling. A single hospitalization, a course of chemotherapy or a long stretch of specialist visits can therefore produce bills that never stop climbing. Every Medicare Advantage plan, by contrast, is legally required to cap that annual spending, a difference that can be worth thousands of dollars in a bad year.
Why Original Medicare has no safety net
Original Medicare was built as a cost-sharing program, not a catastrophic-coverage one. After the annual deductible, Part B generally pays 80% of the approved amount for physician services, outpatient procedures, lab work and durable medical equipment, and the beneficiary owes the remaining 20% on each item. There is no point in the year at which that 20% share stops. Someone with modest health needs may barely notice it, but someone facing cancer treatment, dialysis or repeated surgeries can watch the coinsurance accumulate month after month with nothing to halt it.
Part A adds its own exposure through per-benefit-period hospital deductibles and daily coinsurance charges that begin after extended stays. Because these costs reset with each new benefit period rather than accruing toward any yearly maximum, a person with multiple hospitalizations in a single year can face the hospital deductible more than once. The structure of Medicare costs makes clear that traditional Medicare alone leaves the sickest beneficiaries the most financially exposed, which is the opposite of how most private insurance is designed to work.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
How Medicare Advantage caps the damage
Federal rules require every Medicare Advantage plan to set an annual maximum out-of-pocket limit for in-network care. Once a member’s covered spending reaches that figure, the plan pays 100% of covered services for the rest of the year. For 2026, the federal ceiling for the in-network limit is $9,250, though many plans set theirs lower to compete for enrollees. That cap is the single feature that gives Advantage plans a hard financial floor beneath a catastrophic year, something traditional Medicare simply does not offer on its own.
The protection comes with conditions that matter. The out-of-pocket maximum applies to covered medical services and typically to in-network providers, so care sought outside a plan’s network can be counted under a separate, higher limit or not covered at all. Advantage plans also use networks, referrals and prior authorization to manage costs, trade-offs that do not exist in Original Medicare. The cap is real and valuable, but it sits inside a managed-care structure that restricts where and how a member gets treated.
Prescription drugs are handled under a distinct limit. Medicare’s Part D out-of-pocket cap is $2,100 in 2026, after which covered medications cost nothing for the rest of the year, and that ceiling operates separately from the medical maximum. A beneficiary in an Advantage plan with drug coverage effectively has two backstops, one for medical care and one for prescriptions, while someone on Original Medicare has the drug cap only if they add a standalone Part D plan.
Medigap: the other way to build a ceiling
Beneficiaries who prefer the wider access of Original Medicare can still limit their exposure by adding a Medicare Supplement, or Medigap, policy. These standardized plans pay some or all of the coinsurance, copayments and deductibles that traditional Medicare leaves behind, effectively manufacturing the ceiling that Original Medicare lacks. A comprehensive Medigap plan can reduce a beneficiary’s share of most covered services to little or nothing, turning an open-ended liability into a predictable monthly premium.
The trade-off is cost and timing. Medigap charges a separate monthly premium on top of the Part B premium, and the strongest guarantee to buy a policy regardless of health exists only during the six-month open enrollment window that starts when someone is 65 and enrolled in Part B. Outside that window, insurers in most states can screen applicants and charge more or decline coverage, according to the federal rules on Medigap policies. That makes the initial enrollment period a decision point with lasting financial consequences.
The 2026 cost figures underline why the choice is not academic. The standard Part B deductible is $283 for the year, and the 20% coinsurance applies to Medicare-approved amounts after that, per the agency’s 2026 cost figures. On a large approved charge, that 20% share is not trivial, and it repeats with every covered service across the year.
The comparison ultimately turns on how a beneficiary weighs freedom against predictability. Original Medicare offers unrestricted access to any provider that accepts it but leaves the spending ceiling to be built with Medigap. Medicare Advantage supplies the cap automatically but routes care through a network. Neither answer is universally right, and the harder question is whether a healthy 65-year-old choosing today can accurately forecast the medical year that will eventually test which structure protects them best.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
More Financial Reading
